Nationally Recognized Blood Cancer Specialists

Our team of compassionate caregivers includes highly experienced and skilled physicians who are  thought leaders and innovators in their fields. Our board-certified physicians are nationally recognized for advancing care for malignant blood disorders through their research, clinical trials, publications and society leadership positions, as well as for training Harvard Medical School students and providing graduate medical education.

Medical Oncology

David E. Avigan, MD

Co-Director, Immunotherapy Institute; Section Chief, Hematological Malignancies, Cell Therapy and Bone Marrow Transplant Program

Jon Arnason, MD

Medical Oncology

Salvia Jain, MD

Medical Oncology

Robin M. Joyce, MD

Medical Oncology

Malgorzata McMasters, MD

Instructor, Hematology/Oncology, Harvard Medical School

Lourdes Mendez, MD


Jacalyn Rosenblatt, MD

Deputy Director, Immunotherapy Institute; Medical Director, Cancer Immunotherapy and Cell Manipulation Facility


Matthew J. Weinstock, MD


Infectious Disease 

Carolyn D. Alonso, MD

Director, Transplant Infectious Disease


German A. Pihan, MD

Director, Hematopathology

Dr. Willim

Robert D. Willim, MD


Radiation Oncology 

Mary Ann Stevenson, MD, PhD

Chair and Chief, Radiation Oncology


Kevin J. Donohoe, MD

Nuclear Medicine; Molecular Imaging

Salomao Faintuch, MD

Vascular & Interventional Radiology

Gerald Kolodny, MD


J. Anthony Parker, MD, PhD

Nuclear Medicine

Paul W. Spirn, MD

Diagnostic Radiology

Advanced Practice Providers

Female Doc Silhouette

Amy Corrao, NP

Female Doc Silhouette

Paige DiMambro, NP

Female Doc Silhouette

Nancy Giallombardo, NP

Female Doc Silhouette

Allysa Jankowski, PA

Female Doc Silhouette

Jessica Johnston, PA

Female Doc Silhouette

Eugenia Liacopoulos, NP

Female Doc Silhouette

Jamie Mortellite, NP

Female Doc Silhouette

Ijeoma Ogunlade, NP

Female Doc Silhouette

Carol Silver, NP

Female Doc Silhouette

Margaret Turgeon, NP

The Cancer Center at BIDMC is recognized by the American Society of Clinical Oncology for meeting the highest standards in cancer care.